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Abstract 
Matrix metalloproteinase-9 (MMP-9) plays an important role in both physiological and 
pathological processes. This enzyme is a peripheral biomarker of neuroinflammation in 
multiple sclerosis (MS), a chronic autoimmune disease of the central nervous system. 
Presently, expensive magnetic resonance imaging (MRI) studies are used to monitor 
subclinical disease activity in MS. An alternative to costly MRI scans could be the detection 
of MMP-9, using a low-cost, disposable sensor system for MMP-9 suitable for home-
monitoring of inflammation. This would allow an early prediction of the failure of anti-
inflammatory therapies and more timely clinical intervention to limit neuronal damage and 
prevent disability. Herein we present the development of a disposable sensor for fast and 
straightforward detection of MMP-9. Biosensors were produced by coating electrodes with 
oxidized dextran and subsequent cross-linking with peptides containing specific cleavage 
sites for MMP-9. Exposure of the films to the enzyme resulted in the degradation of the films, 
which was monitored using impedance measurements. Sensor response was rapid, a 
significant impedance change was usually observed within 5 min after the addition of MMP-
9. Sensors showed a negligible response to matrix metalloproteinase-2 (MMP-2), a protease 
which may interfere with MMP-9 detection. The peptide sequence with the highest sensitivity 
and selectivity Leu-Gly-Arg-Met-Gly-Leu-Pro-Gly-Lys was selected to construct calibration 
curves. MMP-9 was successfully detected in a clinically relevant range from 50 to 400 ng/ml. 
Two different processes of hydrogel degradation were observed on electrode surfaces with 
different roughness, and both appeared suitable to monitor MMP-9 activity. The sensor 
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materials are generic and can be easily adopted to respond to other proteases by selecting 
peptide cross-linkers with suitable cleavage sites. 
Keywords: MMP-9 sensor; multiple sclerosis; peptide cross-linked hydrogel; interdigitated 
gold electrodes; electrochemical impedance spectroscopy; film degradation 
 
1 Introduction 
Matrix metalloproteinase-9 (MMP-9) plays a critical role in pathological processes such as 
neuroinflammation in multiple sclerosis (MS) (Fainardi et al., 2006). This is a progressive 
autoimmune disease of the central nervous system affecting over 2.3 million people 
worldwide (Alonso and Hernan, 2008). In MS, inflammation is known to precede the onset of 
clinical attacks or relapses. Although there are therapies for suppressing inflammation, these 
are only partially effective (Comabella et al., 2009). At present, serial magnetic resonance 
imaging (MRI) studies are used to monitor subclinical disease activity in MS. This is not 
ideal as MRI is an expensive monitoring tool, and people with MS (pwMS) have to be 
examined in a hospital setting. Moreover, it would be beneficial to monitor this disease more 
frequently, as it is possible to miss the reoccurring, early phase of inflammation. MMP-9 is 
one of the best studied peripheral biomarkers of neuroinflammation. This biomarker 
correlates with MRI studies in relapsing-remitting multiple sclerosis (RR MS) (Waubant et 
al., 1999). MMP-9 is present in RR MS as an inactive form (92 kDa) and active form (82 
kDa and 65 kDa) (Rossano et al., 2014). Numerous studies show elevated levels of MMP-9 
in people with RR MS. Currently, biochemical assays such as enzyme-linked immunosorbent 
assay (ELISA) (Liuzzi et al., 2002; Avolio et al., 2003; Feinardi et al., 2006 Comabella et al., 
2009; Benesova et al., 2009) and zymography (Rossano et al., 2014) are used for the 
detection of active and/or inactive forms of MMP-9. Avolio et al. (2003) detected active 
MMP-9 at a level of 647.2 ± 333.2 ng/ml (mean ± SD) for short disease duration, 529.1 ± 
370.7 ng/ml for long disease duration, and 326.5 ± 140.3 ng/ml in control samples (Avolio et 
al., 2003). People with MS who responded to therapy showed decreased level of total MMP-
9 (357.7 ± 272 ng/ml) compared to people who did not respond to treatment (442 ± 265.4 
ng/ml) (Comabella et al., 2009).  
 
The above mentioned assays for MMP-9 detection are sensitive; however, the procedures are 
time-consuming, require qualified personnel to perform the analysis and are costly. The 
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drawbacks of these assays can be avoided by employing electrochemical sensors. They may 
detect analytes rapidly and in real-time without many preparation steps that biochemical 
assays require. Moreover, electrochemical devices have potential to be miniaturized, are 
cheap and can be easily operated. A number of electrochemical sensors employing different 
recognition elements have been developed for the detection of MMP-9. Sensors can be 
divided into immunosensors, which were modified with antibodies specific to MMP-9, and 
activity sensors, which were coated with natural or synthetic substrates that were degraded by 
this enzyme (Shoji et al., 2011; Huska et al., 2008; Lee et al., 2009; Ciani et al., 2012). Ciani 
et al. (2012) developed an impedimetric immunosensor with a limit of detection of 1.1 nM 
(100 ng/ml). However, the sensor required incubation with the enzyme for 20 min followed 
by a 5 min washing step. Therefore, this approach may be suitable for constructing a point-
of-care device, but not a meter for home-use. Furthermore, this immunosensor was used for 
detection of the inactive form of MMP-9. There is a need to develop a sensor for active 
MMP-9, since this form (65 kDa) may play a significant role in MS. Rossano et al. (2014) 
detected MMP-9 (65 kDa) only in people with RR MS, which suggests that this truncated 
form correlates with the inflammatory process and not with normal physiological processes 
occurring in the body. MMP-9 was detected by chronopotentiometric stripping analysis on a 
hanging mercury drop electrode in the absence or presence of collagen (Huska et al., 2008) in 
a range from 1 to 10 nM, and the detection limit was 100 pM. Unfortunately, there were 
several disadvantages of using this system. Natural substrates such as collagen have many 
cleavage sites, and sensors may be susceptible to interference from other proteases, which are 
present in blood specimens. Moreover, MMP-9 was not detected in real-time, namely the 
sensor required an enzyme accumulation step that was followed by a rinsing step before the 
measurement was started. This system may be not suitable to construct a disposable sensor. 
Another approach was reported by Shin et al. (2013). They developed a sensor for MMP-9 
detection using the peptide sequence Gly-Pro-Leu-Gly+Met-Trp-Ser-Arg-Cys with attached 
methylene blue as a redox probe. The proteolytic degradation of the peptide sequence was 
monitored by square wave voltammetry showing the detection range from 0.06 to 50 nM 
(Shin et al., 2013). The sensitivity was high, however, the sensor may suffer from 
interference by MMP-2 as the peptide used was described by Netzel-Arnett et al. (1993) as a 
good substrate for both MMP-9 and MMP-2. 
 
Generic sensor materials for the detection of proteases based on thin dextran hydrogel films 
cross-linked with peptides have recently been developed by our group. Degradation of the 
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hydrogel films was monitored using electrochemical impedance (Zheng et al., 2011) and 
Quartz Crystal Microbalance (QCM) measurements (Stair et al., 2009). Good specificity for 
different proteases was achieved by choosing appropriate peptide cross-linkers. This method 
was used successfully to produce sensor materials suitable for the detection of three different 
proteases indicated in periodontal disease, human neutrophil elastase (HNE), cathepsin G and 
MMP-8 (Zheng et al., 2011). In this work, the generic sensor materials were adapted for the 
detection of MMP-9. An important aspect of the sensor development was to limit non-
specific proteolytic degradation of the hydrogel by MMP-2 as this enzyme is closely related 
to MMP-9. Both enzymes contain a fibronectin-like type II module (gelatin binding domain) 
and highly homologous catalytic domains (Olson et al., 2000, Chen et al., 2003). Three 
different peptides have been selected as cross-linkers, having specific cleavage sites for 
MMP-9 and being less susceptible for MMP-2 interference. The enzymatic rate constants for 
the hydrolysis of peptide Ser-Gly-Lys-Gly-Pro-Arg-Gln+Ile-Thr-Ala (SGKGPRQITA) by 
MMP-9 and MMP-2 were kcat/KM=1.88x105 M-1s-1 (Kridel et al., 2001), and kcat/KM=8.4x104 
M-1s-1 (Chen et al., 2003), respectively. The cleavage site was located between glutamine and 
isoleucine. Peptide sequence: Ser-Gly-Ala-Val-Arg-Trp+Leu-Leu-Thr-Ala 
(SGAVRWLLTA) had degradation rate constants kcat/KM=2x105M-1s-1 (MMP-9) and 
kcat/KM=7.0x104 M-1s-1 (MMP-2), with a cleavage site between tryptophan and leucine (Chen 
et al., 2003). These two peptides were modified by adding lysine to obtain amine 
functionality at the C-terminal. A substrate available commercially for HPLC detection of 
MMP-9: Leu-Gly-Arg-Met+Gly-Leu-Pro-Gly-DNP (LGRMGLPG-DNP) with the cleavage 
site between methionine and glycine, (kcat/KM=3.9x105 M-1s-1, data provided by Merck 
Chemicals Ltd.) was adopted for our technology by replacing dinitrophenyl (DNP) with 
lysine to introduce an amino functional group at the C-terminal.  
2 Materials and methods 
2.1 Materials 
Interdigitated gold electrodes were screen printed on 96% alumina and on silicon wafers with 
20 nm SiO2 and 30 nm CVD nitride by the Gwent Group Ltd. (Pontypool, UK); silicon 
wafers with a 40 nm thick thermal silicon dioxide were purchased from (University Wafer 
Inc., USA), proMMP-9 (monomer, human neutrophil, 92 kDa, purity >95%, specific activity 
>1400.0 mU/mg P determined by the producer), proMMP-2 (Human Rheumatoid Synovial 
Fibroblast, 72 kDa, purity >90%, specific activity >850.0 mU/mg P determined by the 
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producer), aminophenyl mercuric acetate were purchased from Merck Chemicals Ltd. 
(Nottingham, UK), peptides LGRMGLPGK, SGKGPRQITAK and SGAVRWLLTAK (95-
98 % purity) were synthesized by Genscript Ltd. (Hong Kong). Each peptide was purified on 
a PL-HCO3 solid phase extraction (SPE) column to remove TFA salts, freeze-dried and 
stored at -20 °C under an argon atmosphere. Columns PL-HCO3 SPE 200 mg/6 ml were 
purchased from Agilent Technologies (Stockport, UK). Dextran from Leuconostocc ssp 
(2000 kDa), cysteamine hydrochloride (purity ≥98%), chromium etchant were purchased 
from Sigma-Aldrich (Dorset, UK). Spectra/Por Float-a-Lyser (MWCO 1000) were from 
Spectrum Laboratories Inc. (California, USA), photoresists SU8 2005 and S1818, EC solvent 
and Developer 351 were purchased from Chestech Ltd. (Rugby, UK), fluorogenic substrate 
Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 (Mca-KPLGL-Dpa-AR-NH2) and 
OmniMMP™ fluorogenic control Mca-Pro-Leu-OH (Mca-PL-OH) were purchased from 
Enzo Life Sciences (Exeter, UK). Other chemicals were obtained from Sigma-Aldrich 
(Dorset, UK) and used without further purification. All solutions were prepared in Milli-Q 
water (18.2 MΩcm resistivity). 
2.2 MMP-9 and MMP-2 activation 
Matrix metalloproteinases (proMMP-9 and proMMP-2) were purchased as inactive forms 
where the active site of these enzymes is blocked by their propeptide domains. P-
aminophenyl mercuric acetate (APMA) is a well-known compound to break the bond 
between propeptide and zinc located in the active domain. A number of autolytic cleavages 
occur after unblocking the zinc dependent active site. It was previously reported that 
activation of MMP-9 by APMA resulted in formation of truncated form of MMP-9 (67 kDa) 
(Shapiro et al., 1995). Activation of MMP-9 was optimized with APMA, and parameters 
which showed the highest activity and stability of MMP-9 were selected.  
MMP-9 was activated by adding APMA, dissolved in 0.1 mM NaOH, to a final concentration 
of 2 mM. The volume ratio was 1:10 (APMA: proMMP-9). Samples were incubated for 30 
min at 37 ºC, and stored at a temperature of 5 ºC. Activity of MMP-9 was tested in 50 mM 
Tris buffer, pH 7.5 containing 10 mM CaCl2, 150 mM NaCl and 0.05% Brij-35 (w/v). 
Degradation of the fluorescence substrate: Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 
(Mca-KPLGL-Dpa-AR) (10 µM) was monitored over 8 min at 25 ºC. A calibration curve for 
control samples (Mca-Pro-Leu-OH) was drawn and the degradation rate (pmoles/min) was 
calculated. The degradation rate for 200 ng/ml of MMP-9 was calculated to be 53 
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pmoles/min immediately after activation, and was stable after 24 h (56 pmoles/min) and 48 h 
(57 pmoles/min). Activated enzyme was stored up to three days and used for impedimetric 
measurements.  
The same parameters were found to be optimal for MMP-2 activation, degradation rate for 
200 ng/ml of MMP-2 was 20 pmoles/min. MMP-2 was activated immediately before 
impedimetric measurements and used the same day.  
2.3 Fabrication of electrodes 
Interdigitated gold electrodes (IDEs) with a diameter of 1.5 mm and paths and gaps of 0.1 
mm were produced by microfabrication. Oxidised silicon wafers were cleaned with piranha 
solution (3:2 v/v H2SO4 and 30% H2O2) for 2 min, dehydrated, followed by chromium and 
gold thermal evaporation (30 nm and 150 nm, respectively) using an Edwards Coating 
System E306A. Photoresist S1818 was spin-coated on gold at 5000 rpm using a CHEMAT 
Technology spin-coater kw-4A. Wafers were prebaked for 10 min at 115 °C and exposed to 
UV light. The photoresist was developed in developer 351 diluted four times in Millipore 
water for 26 seconds. Uncoated gold was etched in potassium triiodide solution consisting of 
5% potassium iodide and 2.5% iodine dissolved in water for 2 min followed by removal of 
chromium in chromium etchant (3 min). Afterwards, arrays were rinsed with acetone and 
isopropanol to remove the photoresist, and were cleaned in piranha solution for 1 min (3:2 
v/v H2SO4 and 30% H202).  
2.4 Dextran oxidation 
Oxidation of dextran (2000 kDa) was carried out in the presence of sodium periodate 
following a procedure described by Ruys et al., (1983). The oxidized dextran solution was 
then dialyzed in Spectra/Por Float-a-Lyser (MWCO 1000) against 2 l of ultrapure water for 
4-5 days. Purified dextran was freeze-dried and stored at a temperature of -20 °C. The degree 
of dextran oxidation was verified by titration according to a procedure developed by Zhao 
and Heindel (1991). The degree of oxidation of aldehyde groups was 80% and was deemed 
sufficient for sensor fabrication. Our previous studies showed the highest degradation rate 
with 75% cross-linked hydrogel prepared for other proteases (Stair et al., 2009). 
2.5 Hydrogel formation 
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A two step-coating method, previously developed by our group (Zheng et al., 2011) was 
adopted to deposit MMP-9 sensitive films. A schematic of the sensor coating process is 
shown in Scheme 1. 
2.5.1 Hydrogel formation on interdigitated gold electrodes (alumina substrate) 
Screen printed IDEs (96 % alumina substrate) were cleaned with piranha solution (3:2 v/v 
solution of sulfuric acid and 30% hydrogen peroxide) for 2 min. A photoresist SU8 2005 was 
deposited to insulate the tracks and define the area of hydrogel deposition. Afterwards, IDEs 
were immersed in 10 mM of cysteamine in 4:1 ethanol and water solution for 1-2 hours 21 °C 
to form a self-assembled monolayer. Electrodes were thoroughly rinsed with water after 
monolayer modification and blow-dried with nitrogen. Dextran (3.3 mg) was dissolved in 250 
µL of pH 8.0 sodium phosphate buffer (10 mM), containing isopropanol (20 %), diluted 5000 
times with the same buffer/isopropanol mixture, and 0.2 µL of the resulting solution was 
drop-coated on the electrodes. Samples were dried for 24 hours over calcium chloride at 30 
°C followed by peptide coating. Peptides LGRMGLPGK (2.4 mg), SGKGPRQITAK (3.0 
mg) and SGAVRWLLTAK (3.1 mg) were dissolved in 62.5 µL of phosphate buffer (10 
mM), pH 8.0, then 62.5 µL of methanol was added. The resulting solution (0.2 µL) was drop-
coated on the dextran layer. Samples were cured for 48-60 hours over sodium bromide, at 30 
°C. Afterwards, sensors were rinsed by dipping them quickly three times in ultrapure water. 
Sensors were stored at 5 °C and used within two weeks. 
2.5.2 Hydrogel formation on interdigitated gold electrodes (silicon substrate) 
Interdigitated gold electrodes obtained by microfabrication or screen printing on silicon 
substrates were cleaned and coated with a cysteamine monolayer using the same 
experimental conditions as described above for screen printed IDEs on alumina substrates. 
Dextran (3.3 mg) was dissolved in 250 µL of phosphate buffer (10 mM), pH 8.0, diluted 
1250 times and 0.4 µL of the resulting solution was drop-coated on the cysteamine 
monolayer. Samples were dried for 24 h over calcium chloride at 30 °C followed by peptide 
coating. Peptide LGRMGLPGK (2.4 mg) was dissolved in 125 µL of sodium phosphate 
buffer (10 mM), pH 8.0, diluted 1000 times in the same buffer. The resulting solution (0.4 
µL) was drop-coated on the dextran layer. Samples were cured for 48 - 60 h over sodium 
bromide, at 30 °C. The mole ratio of functional groups (cysteamine: dextran: peptide) was 
calculated to be approximately 1:4:1 for microfabricated electrodes. Sensors were stored at 5 
°C and used within two weeks. 
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Scheme 1. Schematic of sensor fabrication and the sensing process 
2.6 Monitoring of hydrogel degradation 
Film degradation was monitored by electrochemical impedance spectroscopy. Measurements 
were conducted in a customized cell (1 ml volume) connected to an Autolab PGSTAT30 with 
FRA2 (Windsor Scientific, UK). FRA version 4.9 software was used for all analyses. A small 
perturbation potential (10 mV) was applied to the system and impedance was monitored in a 
frequency range of 10 - 10 000 Hz. Measurements were conducted in 50 mM Tris buffer (pH 
7.5) containing calcium chloride (10 mM) and sodium chloride (150 mM). Studies were 
carried out in the absence or presence of 5 mM potassium ferricyanide and 5 mM potassium 
ferrocyanide at a temperature of 21°C. The cell was filled with buffer (950 µL), and the 
measurement started followed by the addition of enzyme (50 µL) or buffer (50 µL) when a 
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stable background signal was observed. The percentage change of impedance (∆Z) was 
calculated from the magnitude of the impedance recorded before (Z0) and after (Z) exposure 
of the sensor to different concentrations of enzyme: 
∆Z = Z− Z0Z0  ×  100% 
The detection limit was calculated as the concentration of MMP-9 that gave a change of 
impedance equal to the mean value of the blank plus three times the standard deviation (SD) 
of the blank after 5 min of the degradation process. 
3 Results and discussion 
3.1 Cross-linker selection 
Electrochemical impedance spectroscopy was employed to monitor the activity of MMP-9 
and MMP-2 in the following studies. One of the most important tasks was to select a suitable 
substrate for MMP-9. Peptide cross-linkers with good MMP-9 sensitivity were chosen for the 
cross-linking of oxidised dextran films (LGRMGLPGK, SGKGPRQITAK, 
SGAVRWLLTAK), and hydrogels were formed on screen printed, interdigitated gold 
electrodes on alumina substrates as described above (see Materials and Methods and Scheme 
1). As the peptides contained cleavage sites for MMP-9, an exposure of the film to a solution 
containing active MMP-9 was expected to break the cross-links causing a change in the 
impedance of the hydrogel coated electrodes (Scheme 1). Screen printed electrodes were 
selected for sensor development as a large number of electrodes are required for clinical 
trials, and the screen printing technology enables inexpensive disposable sensor systems. The 
impedance spectrum did not show a resistive region in the presence of charge transfer buffer, 
thus the impedance was monitored without the addition of charge transfer probe. Impedance 
was recorded at 10 Hz, 100 Hz, 1 kHz, 10 kHz. The highest sensor responses were recorded 
at 1 kHz. Impedance changes were observed after the addition of MMP-9 with all three 
peptides (Figure 1). Sensors coated with dextran cross-linked with the peptide sequence 
LGRMGLPGK showed a rapid response and the highest sensitivity. An impedance response 
was usually detectable 50 s after the addition of active MMP-9 (200 ng/ml). The signal 
increased by 6.3 % after 20 min of the degradation process. Sensors coated with peptides 
SGKGPRQITAK and SGAVRWLLTAK responded about 3 min later after their exposure to 
MMP-9, and the impedance increased by approximately 2% after 20 min of hydrogel 
degradation (Figure 1).  
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Figure 1. Sensor response to 200 ng/ml MMP-9 at 1 kHz in Tris buffer, pH 7.5. Peptide 
cross-linked hydrogel films were deposited on screen printed gold electrodes on alumina 
 
3.2 Biosensor selectivity 
The peptide cross-linker with the highest sensitivity for MMP-9 (LGRMGLPGK) was tested 
with MMP-2, a gelatinase which may interfere with MMP-9 detection in blood specimens. 
An insignificant response of less than 1% was obtained after the exposure of the film to 
MMP-2 for 20 min demonstrating good selectivity of the sensor (Figure 2). The underlying 
reason for this high selectivity may be the presence of arginine in this sequence. Studies 
performed by Chen et al. (2003) have shown that selectivity of MMP-2 and MMP-9 is 
controlled by the S2 sub-site of the catalytic domains. Sequences of catalytic domains of 
MMP-9 and MMP-2 are His-Ala-Leu-Gly-Leu-Asp-His (HALGLDH) and His-Ala-Met-Gly-
Leu-Glu-His (HAMGLEH), respectively. Therefore, MMP-9 has a preference for Arg at P2 
which is able to interact with Asp at S2. (Chen et al., 2003; Kriedel et al., 2001). These studies 
also clearly indicate that the increase of the impedance resulted from the proteolytic activity 
of the enzymes. 
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Figure 2. Sensor response to 200 ng/ml MMP-2 or MMP-9 at 1 kHz in Tris buffer, pH 7.5. 
Peptide cross-linked hydrogel films were deposited on screen printed gold electrodes on 
alumina 
 
3.3 Monitoring of MMP-9 activity on interdigitated screen printed gold electrodes 
Further studies were conducted in the presence of potassium ferricyanide (5 mM) and 
potassium ferrocyanide (5 mM) to allow measurement of changes in the charge transfer 
resistance at lower frequencies and thereby improve sensor performance. The modification of 
screen printed IDEs was characterized by monitoring the impedance in the frequency range 
from 10 Hz to 10 kHz. Figures 3a and 3b show Bode plots for each modification step. The 
impedance increased after each modification step in the frequency region of the spectra that 
was controlled by interfacial electron transfer and diffusion of the redox probe confirming the 
modification of the electrode surfaces. Impedance spectra were fitted to the Randles 
equivalent circuit and the charge transfer resistance (RCT) was estimated. The RCT of a bare 
electrode was 221.5 Ω and increased after monolayer, and dextran/peptide modification to 
3770 Ω and 6090 Ω, respectively. Activity of MMP-9 was monitored using the film cross-
linked with LGRMGLPGK. Before the addition of the enzyme, a stable impedance was 
observed which suggests that the hydrogel was strongly attached to the surface. Similarly to 
the previous experiments, sensors responded quickly, usually 50 seconds after their exposure 
to enzyme showing an increase in the impedance of approximately 18% after 20 min of 
proteolytic degradation (200 ng/ml MMP-9) (Figure 3c). The increase in impedance was also 
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confirmed by the impedance spectrum measured after degradation (Figure 3a). The charge 
transfer resistance estimated from an equivalent circuit fit showed an increase from 6090 Ω to 
10530 Ω during degradation. The production of hydrogel on screen printed IDEs might have 
resulted in the deposition of very thin, but highly cross-linked films. This could be explained 
by the partial penetration of dextran inside the pores. Therefore, a thinner layer of dextran 
was formed with large number of aldehyde groups accessible for subsequent cross-linking 
with peptide. In the previous studies carried out by Stair et al. (2009) and Zheng et al. (2011) 
similar sensor behaviour was detected using quartz crystals and microfabricated IDEs coated 
with peptide cross-linked hydrogels. They observed an impedance increase and quartz crystal 
frequency decrease initially after the addition of proteases. It was explained that initial 
degradation of the film resulted only in breaking the peptides bonds while the hydrogel was 
still attached to the surface. As a result, thickening of the hydrogel was observed and thus the 
increase of the impedance. This could explain the changes of the impedance of the highly 
cross-linked films deposited on the rough electrodes. This is also consistent with studies 
carried out by Anne et al. (2012) and Shin et al. (2013) who showed that on a rougher 
surface, significantly higher amounts of peptide were not degraded compared to a very even 
surface. The percentage of non-cleavable peptides was usually 40% of total coverage on the 
polished gold electrodes possibly due to the presence of molecular-scale grooves. On an 
extremely flat gold surface, less than 10 % of peptides were not degraded (Anne et al., 2012). 
Therefore, it is possible that swelling of the film was observed instead of its dissolution as a 
result of partial degradation of peptides on screen printed IDEs. Additionally, films may be 
protected in pores. However swelling due to a reduced cross-link density caused by the 
cleavage of peptide cross-links does not explain the increase in impedance as a greater influx 
of water should also result in an increase in the ferri/ferrocyanide concentration in the film. 
There are three possible explanations for this behaviour (Zheng et al., 2011): (i) Only the 
surface of the film is highly cross-linked. Degradation of the top layer of the film exposes 
unreacted aldehyde groups, which can react with the protein. Protein binding could reduce 
the concentration of ferri/ferrocyanide in the film. (ii) If the electrode surface is initially 
incompletely covered with hydrogel, expansion of the film due to swelling could result in a 
greater surface coverage thereby impeding the access of charge transfer reagent to the 
surface. (iii) Peptide cleavage results in the formation of carboxylic acid groups and amino 
groups. The negative charge of the carboxylate group at pH 7.4 could cause the 
ferri/ferrocyanide to be expelled. However, this effect would be counteracted by the 
formation of positively charged amino groups.  
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The increase in impedance was also seen previously when using oxidised dextran films cross-
linked with a different peptide (AAPVAAK) on screen printed electrodes for the detection of 
human neutrophil elastase (HNE) (see general discussion of (Zheng et al., 2011)). In this 
case, the impedance was also stable in buffer and increased rapidly when exposed to 
solutions containing HNE. Although unexpected, this result was highly reproducible in both 
this and previous studies on such electrodes. 
Linear calibration curves were obtained by plotting impedance changes versus MMP-9 
concentration after 5, 10 and 20 min of the film degradation. The enzyme was detected in a 
clinically relevant range from 50 to 400 ng/ml (Figures 3c and 3d). The detection limit (15 
ng/ml) was lower than the level of MMP-9 reported in patients with RR MS which is 
beneficial as levels of the enzyme may vary between patients (Avolio et al., 2003), and also 
differences may be observed in different specimens such as serum and plasma (Gerlach et al., 
2007). 
 
Figure 3. (a and b) Impedance spectra of screen printed IDEs before and after coating with a 
cysteamine monolayer, after coating with peptide cross-linked dextran hydrogel and after 
hydrogel degradation by 400 ng/ml MMP-9 in charge transfer buffer, pH 7.5. (c) Sensor 
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responses to different concentrations of MMP-9 (ng/ml) in charge transfer buffer, pH 7.5 at 
10 Hz (MMP-9 was added at 8.3 min as indicated by the arrow.) and (d) the calibration 
curves showing ΔZ after exposure of the sensor to MMP-9 for different periods of time. The 
error bars represent ±SD (n=3). Sensors were produced on screen printed IDEs (silicon 
substrate). RSD calculated after 20 min of the film degradation was 33.3; 29.4; 5.82; 14.4; 
0.66 % for 0; 50; 100; 200; 400 ng/ml MMP-9, respectively. 
3.4 Monitoring of MMP-9 activity on microfabricated interdigitated gold electrodes  
Interdigitated gold electrodes produced by microfabrication were used to verify the influence 
of the roughness of electrodes on sensor responses. The modification of microfabricated IDEs 
was also characterized by monitoring the impedance in the frequency range from 10 Hz to 10 
kHz. Figures 4a and 4b show Bode plots for each modification step and after degradation in 
the presence of MMP-9. Data were fitted to the Randles equivalent circuit and the charge 
transfer resistance (RCT) was estimated. The RCT of a bare electrode was 413 Ω and increased 
after monolayer, dextran/peptide modification to 1500 Ω and 32100 Ω, respectively. This 
confirmed the successful modification of electrode surfaces. The charge transfer resistance of 
the hydrogel modified electrodes was significantly larger for the microfabricated electrodes 
compared to the screen printed electrodes (see Figure 3a). This indicates that much better 
coating quality was achieved on the smoother surface of the microfabricated electrodes. The 
maximum phase angle observed for screen printed electrodes coated with peptide cross-
linked hydrogel was 43 degrees (Figure 3b) due to high surface roughness of the electrodes 
and therefore the hydrogel film, while the maximum phase angle for microfabricated 
electrodes was about 73 degrees in the capacitive region (Figure 4b) indicating lower 
roughness of the hydrogel coating as compared to screen printed IDEs (Figure 3b). Figure 4 
shows impedance spectra recorded in the absence and presence of MMP-9 in charge transfer 
buffer. The impedance spectrum after degradation was recorded 20 min after the addition of 
enzyme to the cell and showed a significant decrease in impedance. The highest sensor 
response, around 40 %, was detected in the resistive part of the spectrum at low frequencies 
between 10 - 100 Hz. This indicates that the hydrogel was dissolved and electron transfer 
between the electrode and the redox couple was facilitated. The impedance changes were not 
observed in the capacitive region, at higher frequencies between 1 kHz - 10 kHz. This may be 
attributed to the hydrophilicity of the films and uptake of electrolyte before hydrogel 
degradation. 
15 
 
Impedance changes at different concentrations of enzyme (50-200 ng/ml) were measured at 
100 Hz (Figure 4c). The background impedance was stable before the addition of MMP-9. 
Rapid degradation was recorded during the first 10 min after the exposure of the sensor to 
MMP-9 (200 ng/ml), where impedance decreased by about 38 %. The degradation rate can be 
improved further by employing the optimum temperature for MMP-9 activity, which is 37°C 
(Increasing the temperature from 25°C to 37°C increases kcat of MMP-9 approximately by a 
factor of 4 (Fasciglione et al., 2000)). The impedance further decreased by 5% in another 10 
min (Figure 4c). Dextran was probably cross-linked only on the surface as a result of using a 
two step-coating method for sensor preparation and thus rapid degradation of the film was 
monitored over the first min. The low degradation rate at the end of the measurement (Figure 
4c) may suggest that most of the substrate was degraded by the enzyme. However, 
significantly higher impedance of this sensor after 20 min of hydrogel degradation compared 
to electrodes coated with a monolayer (Figure 4a) indicates that only part of hydrogel was 
dissolved after proteolytic degradation.  These results suggest that dextran was covalently 
bound to the amino terminated monolayer. Incomplete degradation of peptides could be also 
possible. As mentioned above, this was observed by Anne et al. (2012) even on extremely 
flat gold surfaces. The stability of the dextran layer and incomplete dissolution may also 
result from the high molecular weight of dextran that was used in our studies (2000 kDa).  
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Figure 4. (a and b) Impedance spectra of microfabricated IDEs before and after coating with 
a cysteamine monolayer, after coating with peptide cross-linked dextran hydrogel and after 
hydrogel degradation by 200 ng/ml MMP-9 in charge transfer buffer, pH 7.5. (c) Sensor 
responses for different concentration of MMP-9 (ng/ml) in charge transfer buffer, pH 7.5 at 
10 Hz (MMP-9 was added at 8.3 min as indicated by the arrow.) and (d) the calibration 
curves showing ΔZ after exposure of the sensor to MMP-9 for different periods of time. The 
error bars represent ±SD (n=3). RSD calculated after 20 min of the film degradation was -
25.2; -29; -5.3; -13.6 % for 0; 50; 100; 200 ng/ml MMP-9, respectively. 
4 Conclusions 
MMP-9 was successfully detected in a clinically relevant range for relapsing remitting 
multiple sclerosis. Importantly, the sensor materials showed a negligible response to identical 
concentrations of MMP-2 which may also be present in blood specimen, demonstrating a 
possibility for using the MMP-9 sensor for analysis of plasma samples. Two different 
processes of hydrogel degradation were observed on electrode surfaces with different 
roughness resulting in an increase of impedance on rough electrodes and a decrease of 
impedance on smoother, microfabricated electrodes. It is assumed that the films were more 
likely to remain on the rough electrodes after degradation as some of the hydrogel was 
trapped in the pores and a smaller percentage of peptide cross-links was expected to be 
cleaved. For smooth electrodes, a larger percentage of peptide-crosslinks was expected to be 
cleaved by the enzyme resulting in the dissolution of a larger proportion of the films. 
Electrodes prepared by both, microfabrication and screen printing, are suitable to monitor 
MMP-9 activity. Not only are the measurements straightforward and MMP-9 is detected in 
real-time, but also the fabrication process is simple, which will allow mass production of 
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these sensors. The sensor performance and its repeatability will be further improved by 
deposition of the hydrogel by an automated dispensing system such as BioDot. Moreover, 
materials used for the development of disposable MMP-9 sensor are generic and can be used 
for detection of other proteases by changing the peptide sequence. 
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